Markowski Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Markowski Investments’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1K	Buy	+105	New	+$1.85K	﹤0.01%	540

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

BBPWM

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return

UPS

UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Markowski Investments's HQL Position: Q2 2026 in Review

Markowski Investments opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 105 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #540 among its holdings.

65 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Markowski Investments held 105 shares of abrdn Life Sciences Investors worth $2.1K as of Q2 2026.
abrdn Life Sciences Investors was a new Markowski Investments position in Q2 2026.
abrdn Life Sciences Investors made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #540 holding.
65 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.